Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

• Knut B. Smeland,
• Cecilie E. Kiserud,
• Grete F. Lauritzsen,
• Unn-Merete Fagerli,
• Ragnhild S. Falk,
• Øystein Fluge,
• Alexander Fosså,
• Arne Kolstad,
• Jon H. Loge,
• Martin Maisenhölder,
• Stein Kvaløy,
• Harald Holte

Affiliations

Knut B. Smeland

National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway;Faculty of Medicine, University of Oslo, Norway

Cecilie E. Kiserud

National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway

Grete F. Lauritzsen

Department of Oncology, Oslo University Hospital, Norway

Unn-Merete Fagerli

Department of Oncology, St. Olavs Hospital, Trondheim, Norway;Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway

Ragnhild S. Falk

Oslo Center for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Norway

Øystein Fluge

Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway

Alexander Fosså

Department of Oncology, Oslo University Hospital, Norway

Arne Kolstad

Department of Oncology, Oslo University Hospital, Norway

Jon H. Loge

National Advisory Unit on Late Effects, Department of Oncology, Oslo University Hospital, Norway;Department of Behavioural Sciences in Medicine, Faculty of Medicine, University of Oslo, Norway

Martin Maisenhölder

Department of Oncology, University Hospital of North Norway, Tromsø, Norway

Stein Kvaløy

Faculty of Medicine, University of Oslo, Norway;Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Norway

Harald Holte

Department of Oncology, Oslo University Hospital, Norway